Search results for "Prostate Cancer"
Propoxyphene withdrawn, bevacizumab loses indication
Recalls, warnings, and approvals.
https://immattersacp.org/archives/2011/02/fda.htm
1 Feb 2011
Surgery associated with less prostate cancer mortality than surveillance
Radical prostatectomy was associated with fewer deaths from prostate cancer compared to watchful waiting, a Scandinavian study found. But the results may not apply in the U.S., where more prostate-specific antigen testing occurs.
https://immattersacp.org/weekly/archives/2011/05/10/4.htm
10 May 2011
Well visits not just for kids anymore
Medicare now reimburses for annual physical exams, so prepare your office, your patients and yourself for the best way to accommodate this into your practice.
https://immattersacp.org/archives/2011/06/wellness.htm
1 Jun 2011
Aiding patients' decisions on PSA screening
Routine prostate-specific antigen (PSA) screening of all men over a certain age began about 20 years ago, but the certainty about whether that was or is wise medical practice is long gone.
https://immattersacp.org/archives/2011/07/prostate.htm
1 Jul 2011
Warfarin recalled, type 2 diabetes drug approved
Recalls, warnings, and approvals.
https://immattersacp.org/archives/2011/07/fda.htm
1 Jul 2011
Are your patients health literate?
Determining a patient's health literacy can be a challenge for physicians.
https://immattersacp.org/archives/2011/07/editors.htm
1 Jul 2011
Updating family cancer history may change screening recommendations
Updating patients' family history of cancer during adulthood may lead to changes in recommended cancer screenings, according to a new study.
https://immattersacp.org/weekly/archives/2011/07/19/1.htm
19 Jul 2011
Model predicts erectile function after prostate cancer
Researchers have developed a new model to predict the risk of erectile dysfunction for men undergoing prostate cancer treatment.
https://immattersacp.org/weekly/archives/2011/09/27/4.htm
27 Sep 2011
NIH panel advocates delaying treatment for low-grade prostate cancer
Men with localized, low-risk prostate cancer should be closely monitored until disease progression warrants treatment, concluded an independent panel of the National Institutes of Health.
https://immattersacp.org/weekly/archives/2011/12/13/1.htm
13 Dec 2011
CONFERENCE COVERAGE Information plus documentation a must for informed ...
In 1990, Dr. Gottesman was sued forlate diagnosis of a patient’s prostate cancer.He won the case, and one of the jurors toldhim that the deciding factor had beeninformed consent ... documentation showingthat the patient had been warned that abiopsy could miss cancer.
https://immattersacp.org/archives/2012/01/acpi-201201-coding_t4.pdf
19 Dec 2011